Free Trial
→ Market Panic: Trump Just Dropped a Bomb on Your Stocks (From American Alternative) (Ad) Free NGNE Stock Alerts

Neurogene (NGNE) SEC Filings & 10K Form

Neurogene logo
$21.43 -0.53 (-2.41%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$20.98 -0.45 (-2.08%)
As of 07/11/2025 06:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Neurogene SEC Filings

Export to Excel
DateFilerForm TypeView
06/30/2025
3:02 PM		Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2025
11:05 AM		Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
Noonberg Sarah B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
11:06 AM		Freedland Cory S. (Reporting)
Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
11:06 AM		Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
PALEKAR ROHAN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
11:07 AM		Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
Woods Robert Keith (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2025
11:07 AM		BAFFI ROBERT (Reporting)
Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
6:25 AM		Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
3:43 PM		Cobb Stuart (Reporting)
Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025
6:19 AM		Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2025
6:30 AM		Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2025
9:01 AM		Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
Form ARS
04/25/2025
8:53 AM		Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
Form DEF 14A
04/25/2025
8:54 AM		Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
Form DEFA14A
04/23/2025
7:57 PM		BlackRock, Inc. (Filed by)
Neurogene Inc. (Subject)
Neurogene Inc. (Subject)
Neurogene (Subject)
Form SCHEDULE 13G/A
04/06/2025
11:15 PM		Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
Form EFFECT
04/01/2025
4:22 PM		Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
Form 424B3
03/30/2025
11:15 PM		Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
Form EFFECT
03/28/2025
8:27 PM		McMinn Rachel (Reporting)
Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
8:28 PM		Jordan Julie (Reporting)
Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
8:29 PM		Cvijic Christine Mikail (Reporting)
Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
8:30 PM		Cobb Stuart (Reporting)
Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
3:30 PM		Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/24/2025
3:32 PM		Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
Form POS AM
03/24/2025
3:34 PM		Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/24/2025
3:14 PM		Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2025
4:14 PM		Cvijic Christine Mikail (Reporting)
Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
7:01 PM		Neurogene Inc. (Subject)
Neurogene Inc. (Subject)
Neurogene (Subject)
Redmile Group, LLC (Filed by)
Form SCHEDULE 13G/A
02/14/2025
10:34 AM		JANUS HENDERSON GROUP PLC (Filed by)
Neurogene Inc. (Subject)
Neurogene Inc. (Subject)
Neurogene (Subject)
Form SCHEDULE 13G/A
02/14/2025
8:00 AM		Neurogene Inc. (Subject)
Neurogene Inc. (Subject)
Neurogene (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SCHEDULE 13G/A
01/13/2025
6:30 AM		Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
3:01 PM		Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
Form 424B3
12/16/2024
11:15 PM		Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
Form EFFECT
12/11/2024
3:05 PM		COMMODORE CAPITAL LP (Filed by)
Neurogene Inc. (Subject)
Neurogene Inc. (Subject)
Neurogene (Subject)
Form SC 13G
12/02/2024
4:27 PM		Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
Form S-1
Registration statement under Securities Act of 1933  
11/27/2024
3:36 PM		AKKARAJU SRINIVAS (Reporting)
Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
Samsara BioCapital GP, LLC (Reporting)
Samsara BioCapital, L.P. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/25/2024
8:29 PM		McMinn Rachel (Reporting)
Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
8:29 PM		Cvijic Christine Mikail (Reporting)
Neurogene Inc. (Issuer)
Neurogene Inc. (Issuer)
Neurogene (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2024
3:01 PM		Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
4:26 PM		Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
4:27 PM		Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/18/2024
5:50 AM		Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
I was wrong about Trump (Ad)

I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.

Let me show you exactly what we’re doing to prepare.
11/14/2024
3:53 PM		GREAT POINT PARTNERS LLC (Filed by)
Neurogene Inc. (Subject)
Neurogene Inc. (Subject)
Neurogene (Subject)
Form SC 13G/A
11/14/2024
2:24 PM		JANUS HENDERSON GROUP PLC (Filed by)
Neurogene Inc. (Subject)
Neurogene Inc. (Subject)
Neurogene (Subject)
Form SC 13G/A
11/14/2024
2:05 PM		Cormorant Asset Management, LP (Filed by)
Neurogene Inc. (Subject)
Neurogene Inc. (Subject)
Neurogene (Subject)
Form SC 13G/A
11/14/2024
5:22 AM		Neurogene Inc. (Subject)
Neurogene Inc. (Subject)
Neurogene (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G
11/04/2024
6:33 AM		Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
3:15 PM		Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2024
6:31 AM		Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
6:31 AM		Neurogene Inc. (Filer)
Neurogene Inc. (Filer)
Neurogene (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:NGNE) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...
Paradigm Press | Sponsored
[No Brainer Gold Play]: “Show me a better investment.”
A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...
Golden Portfolio | Sponsored
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...
Stansberry Research | Sponsored
Banks aren’t ready for this altcoin—are you?
Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...
Crypto 101 Media | Sponsored